Crossmark

Investigate sodium orthovanadate molecular mechanisms in diabetes-aggravated ulcerative colitis, focusing on Nrf2/Keap1 antioxidant and NF-κB/IL-6 inflammatory pathways

Crossref DOI link: https://doi.org/10.1007/s10735-026-10765-8

Published Online: 2026-03-12

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kaur, Gurpreet

Kushwah, Ajay Singh https://orcid.org/0000-0003-0559-7670
License Information

Text and Data Mining valid from 2026-03-12

Version of Record valid from 2026-03-12
More Information

Article History

Received: 17 December 2025

Accepted: 26 February 2026

First Online: 12 March 2026

Declarations

:

: The authors declare no competing interests.

: The experiments were carried out in compliance with ethical standards for animal experimentation by the Committee for Control and Supervision of Experiments on Animals (CCSEA), Government of India, New Delhi. The current research plan was authorized by the Institutional Animal Ethics Committee (IAEC) of Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela 140111, Ropar, Punjab, India, under the designated ASCB/IAEC/18/23/180 reference number.

Document is current

Any future updates will be listed below